Your browser doesn't support javascript.
loading
Effects of an Intensive Discharge Intervention on Medication Adherence, Glycemic Control, and Readmission Rates in Patients With Type 2 Diabetes.
Magny-Normilus, Cherlie; Nolido, Nyryan V; Borges, Jorge C; Brady, Maureen; Labonville, Stephanie; Williams, Deborah; Soukup, Jane; Lipsitz, Stuart; Hudson, Margo; Schnipper, Jeffrey L.
Afiliação
  • Nolido NV; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
  • Borges JC; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
  • Brady M; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
  • Labonville S; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
  • Williams D; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
  • Soukup J; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lipsitz S; From the Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
J Patient Saf ; 17(2): 73-80, 2021 03 01.
Article em En | MEDLINE | ID: mdl-31009408
OBJECTIVES: Patients with diabetes are at particularly high risk for adverse outcomes after hospitalization. The goals of this study were to design, implement, and evaluate a multipronged transitional care intervention among hospitalized patients with diabetes. METHODS: We randomly assigned inpatients likely to be discharged home on insulin to an intensive transitional care intervention or usual care. The primary outcome was 90-day postdischarge insulin adherence, using prescription refill information to calculate a medication possession ratio. Unadjusted analyses were conducted using Wilcoxon rank sum; adjusted analyses used multivariable linear regression and weighted propensity scoring methods, with general estimating equations to account for clustering by admitting physician. RESULTS: One hundred eighty patients participated. The mean (SD) medication possession ratio to all insulin types was 84.5% (22.6) among intervention and 76.4% (25.1) among usual care patients (difference = 8.1, 95% confidence interval = -1.0 to 17.2, P = 0.06), with a smaller difference for adherence to all medications (86.3% versus 82.0%). A1c levels decreased in both groups but was larger in the intervention arm (1.09 and 0.11, respectively) (difference = -0.98, 95% confidence interval = -2.03 to -0.07, P = 0.04). Differences between study arms were not significant for rates of hypoglycemic episodes, 30-day readmissions, or emergency department visits. In adjusted/clustered analyses, the difference in A1c reduction remained statistically significant, whereas differences in all other outcomes remained nonsignificant. CONCLUSIONS: The intervention was associated with improvements in glycemic control, with nonsignificant trends toward greater medication adherence. Further research is needed to optimize and successfully implement interventions to improve patient safety and health outcomes during care transitions.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alta do Paciente / Readmissão do Paciente / Adesão à Medicação / Controle Glicêmico Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alta do Paciente / Readmissão do Paciente / Adesão à Medicação / Controle Glicêmico Idioma: En Ano de publicação: 2021 Tipo de documento: Article